Generic placeholder image

The Natural Products Journal

Editor-in-Chief

ISSN (Print): 2210-3155
ISSN (Online): 2210-3163

Mini-Review Article

A Mini Review of Underutilized Native Plants from East Malaysia’s Rainforests as Potential Hypertensive Drugs

Author(s): Fong Tyng Chee, Su Na Chin and Fui Fui Lem*

Volume 13, Issue 2, 2023

Published on: 08 September, 2022

Article ID: e120522204701 Pages: 7

DOI: 10.2174/2210315512666220512203341

Price: $65

Open Access Journals Promotions 2
Abstract

Hypertension is a risk factor for cardiovascular diseases, which are on the rise throughout the world at an alarming rate. As a result, a variety of techniques to help in the prevention and control of hypertension have been tried, one of which is the use of natural medicines derived from medicinal plants. The relevance of plant-based medicine is now recognised by western countries, as seen by Canada's Natural Health Product Regulations, which were promulgated in January 2004. The Southeast Asian rainforests, notably in East Malaysia, are home to a diverse range of medicinal plant species with endless potential as pharmacological candidates, particularly as antihypertensive agents. The indigenous ethnic groups of East Malaysia have long utilised a wide variety of medicinal plant species to treat hypertension, thanks to their extensive usage of traditional remedies and in-depth understanding of ethnomedicine, which are fundamental elements of their culture. However, scientific understanding of ethnomedicines used to treat hypertension, particularly the processes underlying their antihypertensive action, is inadequate. Based on previous scientific studies, this review aims to address the antihypertensive effects of medicinal plants used by indigenous ethnic groups in East Malaysia, Sabah, in order to provide insights into the mechanisms of the plants' antihypertensive activity for the development of antihypertensive agents from these native plants.

Keywords: Potential hypertensive drugs, ethnobotany, ethnomedicine, anti-hypertensive, hypertension, cardiovascular diseases.

[1]
Naing, C.; Yeoh, P.N.; Wai, V.N.; Win, N.N.; Kuan, L.P.; Aung, K. Hypertension in Malaysia. An analysis of trends from the national surveys 1996 to 2011. Medicine (Baltimore), 2016, 95(2), e2417.
[http://dx.doi.org/10.1097/MD.0000000000002417] [PMID: 26765422]
[2]
Lim, T.O.; Morad, Z. Prevalence, awareness, treatment and control of hypertension in the Malaysian adult population: results from the national health and morbidity survey 1996. Singapore Med. J., 2004, 45(1), 20-27.
[PMID: 14976578]
[3]
Lim, O.W.; Yong, C.C. The analysis of risk factor among diagnosed hypertension individuals in Malaysia: A population study. Adv. Sci. Lett., 2017, 23(9), 9220-9223.
[http://dx.doi.org/10.1166/asl.2017.10058]
[4]
Sacks, F.M.; Campos, H. Dietary therapy in hypertension. N. Engl. J. Med., 2010, 362(22), 2102-2112.
[http://dx.doi.org/10.1056/NEJMct0911013] [PMID: 20519681]
[5]
Chobanian, A.V.; Bakris, G.L.; Black, H.R.; Cushman, W.C.; Green, L.A.; Izzo, J.L., Jr; Jones, D.W.; Materson, B.J.; Oparil, S.; Wright, J.T., Jr; Roccella, E.J. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension, 2003, 42(6), 1206-1252.
[http://dx.doi.org/10.1161/01.HYP.0000107251.49515.c2] [PMID: 14656957]
[6]
Lem, F.F.; Opook, F.; Lawson, F.P.; Yong, W.T.L.; Chee, F.T. Network pharmacology and component analysis of four herbs decoction molecular mechanism in hypertension treatment. New Biol., 2021, 11, 54-67.
[7]
Siow, Y.L.; Gong, Y.; Au-Yeung, K.K.; Woo, C.W.; Choy, P.C.; O, K. Emerging issues in traditional Chinese medicine. Can. J. Physiol. Pharmacol., 2005, 83(4), 321-334.
[http://dx.doi.org/10.1139/y05-029] [PMID: 15877107]
[8]
Orhan, I.E. Biotechnology production of plant secondary metabolites; Bentham Science Publishers, 2012.
[http://dx.doi.org/10.2174/97816080511441120101]
[9]
Juárez, P. Plant-derived anticancer agents: A promising treatment for bone metastasis. Bonekey Rep., 2014, 3, 599.
[http://dx.doi.org/10.1038/bonekey.2014.94] [PMID: 28243436]
[10]
Ahmad, F.B.; Hldsworth, D.K. Medicinal plants of Sabah, East Malaysia – Part I. Pharm. Biol., 2003, 41(5), 340-346.
[http://dx.doi.org/10.1076/phbi.41.5.340.15940]
[11]
Kunjuraman, V. The identification of floras used as traditional and complementary medicine: A study in Ramsar site, Sabah, Malaysia. J. Biomed. Clin. Sci., 2018, 3, 68-71.
[12]
Williams, J.E. Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on Una de Gato and Sangre de Grado. Altern. Med. Rev., 2001, 6(6), 567-579.
[PMID: 11804547]
[13]
Zakaria, M.; Mohd, M.A. Traditional Malay medicinal plants; Institut Terjemahan Negara Malaysia, 2010.
[14]
Tammu, J.; Ramana, K.V.; Thalla, S.; Narasimha Raju, B.H. Diuretic activity of methanolic extract of Physalis minima leaves. Pharm. Lett., 2012, 4, 1832-1834.
[15]
Tomaschitz, A.; Pilz, S.; Ritz, E.; Obermayer-Pietsch, B.; Pieber, T.R. Aldosterone and arterial hypertension. Nat. Rev. Endocrinol., 2010, 6(2), 83-93.
[http://dx.doi.org/10.1038/nrendo.2009.263] [PMID: 20027193]
[16]
Nugrahenny, D.; Permatasari, N.; Rohman, M.S. Physalis minima leaves extract induces re-endothelialization in deoxycorticosterone acetate-salt-induced endothelial dysfunction in rats. Research. J. Life Sci., 2017, 4, 199-208.
[17]
Machin, R.P.; Veleiro, A.S.; Nicotra, V.E.; Oberti, J.C.; M Padrón, J. Antiproliferative activity of with anolides against human breast cancer cell lines. J. Nat. Prod., 2010, 73(5), 966-968.
[http://dx.doi.org/10.1021/np9006734] [PMID: 20438092]
[18]
Lestari, B; Permatasari, N; Rohman, MS. Methanolic extract of ceplukan leaf (Physalis minima L.) attenuates ventricular fibrosis through inhibition of TNF-α in ovariectomized rats. Adv. Pharmacol. Pharm. Sci., 2016, 7, 2428052.
[19]
Lee, S.D.; Kuo, W.W.; Ho, Y.J.; Lin, A.C.; Tsai, C.H.; Wang, H.F.; Kuo, C.H.; Yang, A.L.; Huang, C.Y.; Hwang, J.M. Cardiac Fas-dependent and mitochondria-dependent apoptosis in ovariectomized rats. Maturitas, 2008, 61(3), 268-277.
[http://dx.doi.org/10.1016/j.maturitas.2008.07.004] [PMID: 18951737]
[20]
Patel, A; Spangenburg, EE; Witkowski, S Ovariectomy induces early changes in cardiac fibrosis and angiotensin II gene expression. Poster Presentation. UMass Center for Clinical and Translational Science Research Retreat, 2014.
[21]
van Eickels, M.; Grohé, C.; Cleutjens, J.P.M.; Janssen, B.J.; Wellens, H.J.J.; Doevendans, P.A. 17β-estradiol attenuates the development of pressure-overload hypertrophy. Circulation, 2001, 104(12), 1419-1423.
[http://dx.doi.org/10.1161/hc3601.095577] [PMID: 11560859]
[22]
Babiker, F.A.; Lips, D.; Meyer, R.; Delvaux, E.; Zandberg, P.; Janssen, B.; van Eys, G.; Grohé, C.; Doevendans, P.A. Estrogen receptor β protects the murine heart against left ventricular hypertrophy. Arterioscler. Thromb. Vasc. Biol., 2006, 26(7), 1524-1530.
[http://dx.doi.org/10.1161/01.ATV.0000223344.11128.23] [PMID: 16627800]
[23]
Haudek, S.B.; Taffet, G.E.; Schneider, M.D.; Mann, D.L. TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J. Clin. Invest., 2007, 117(9), 2692-2701.
[http://dx.doi.org/10.1172/JCI29134] [PMID: 17694177]
[24]
Deswal, A.; Petersen, N.J.; Feldman, A.M.; Young, J.B.; White, B.G.; Mann, D.L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation, 2001, 103(16), 2055-2059.
[http://dx.doi.org/10.1161/01.CIR.103.16.2055] [PMID: 11319194]
[25]
Burkill, I.H. A dictionary of the economic products of the Malay Peninsula; Ministry of Agriculture and Cooperation: Kuala Lumpur, Malaysia, 1966.
[26]
Adeneye, A.A.; Benebo, A.S. Protective effect of the aqueous leaf and seed extract of Phyllanthus amarus on gentamicin and acetaminophen-induced nephrotoxic rats. J. Ethnopharmacol., 2008, 118(2), 318-323.
[http://dx.doi.org/10.1016/j.jep.2008.04.025] [PMID: 18554830]
[27]
Barros, M.E.; Schor, N.; Boim, M.A. Effects of an aqueous extract from Phyllantus niruri on calcium oxalate crystallization in vitro. Urol. Res., 2003, 30(6), 374-379.
[http://dx.doi.org/10.1007/s00240-002-0285-y] [PMID: 12599017]
[28]
Lee, N.Y.; Khoo, W.K.; Adnan, M.A.; Mahalingam, T.P.; Fernandez, A.R.; Jeevaratnam, K. The pharmacological potential of Phyllanthus niruri. J. Pharm. Pharmacol., 2016, 68(8), 953-969.
[http://dx.doi.org/10.1111/jphp.12565] [PMID: 27283048]
[29]
Hackam, D.G.; Khan, N.A.; Hemmelgarn, B.R.; Rabkin, S.W.; Touyz, R.M.; Campbell, N.R.; Padwal, R.; Campbell, T.S.; Lindsay, M.P.; Hill, M.D.; Quinn, R.R.; Mahon, J.L.; Herman, R.J.; Schiffrin, E.L.; Ruzicka, M.; Larochelle, P.; Feldman, R.D.; Lebel, M.; Poirier, L.; Arnold, J.M.; Moe, G.W.; Howlett, J.G.; Trudeau, L.; Bacon, S.L.; Petrella, R.J.; Milot, A.; Stone, J.A.; Drouin, D.; Boulanger, J.M.; Sharma, M.; Hamet, P.; Fodor, G.; Dresser, G.K.; Carruthers, S.G.; Pylypchuk, G.; Burgess, E.D.; Burns, K.D.; Vallée, M.; Prasad, G.V.; Gilbert, R.E.; Leiter, L.A.; Jones, C.; Ogilvie, R.I.; Woo, V.; McFarlane, P.A.; Hegele, R.A.; Tobe, S.W. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can. J. Cardiol., 2010, 26(5), 249-258.
[http://dx.doi.org/10.1016/S0828-282X(10)70379-2] [PMID: 20485689]
[30]
Tsabang, N.; Yedjou, C.G.; Tsambang, L.W.D.; Tchinda, A.T.; Donfagsiteli, N.; Agbor, G.A.; Tchounwou, P.B.B.; Nkongmeneck, B.A. Treatment of diabetes and/or hypertension using medicinal plants in cameroon. Med. Aromat. Plants, 2015, 2, 003.
[31]
Iizuka, T.; Moriyama, H.; Nagai, M. Vasorelaxant effects of methyl brevifolincarboxylate from the leaves of Phyllanthus niruri. Biol. Pharm. Bull., 2006, 29(1), 177-179.
[http://dx.doi.org/10.1248/bpb.29.177] [PMID: 16394535]
[32]
Thippeswamy, A.H.; Shirodkar, A.; Koti, B.C.; Sadiq, A.J.; Praveen, D.M.; Swamy, A.H.; Patil, M. Protective role of Phyllantus niruri extract in doxorubicin-induced myocardial toxicity in rats. Indian J. Pharmacol., 2011, 43(1), 31-35.
[http://dx.doi.org/10.4103/0253-7613.75663] [PMID: 21455418]
[33]
Bello, I.; Usman, N.S.; Dewa, A.; Abubakar, K.; Aminu, N.; Asmawi, M.Z.; Mahmud, R. Blood pressure lowering effect and vascular activity of Phyllanthus niruri extract: The role of NO/cGMP signaling pathway and β-adrenoceptor mediated relaxation of isolated aortic rings. J. Ethnopharmacol., 2020, 250, 112461.
[http://dx.doi.org/10.1016/j.jep.2019.112461] [PMID: 31830549]
[34]
Yuan, Y.; Pang, Y.X.; Wang, W.Q.; Zhang, Y.B.; Yu, J.B.; Zhu, M. Research advances in the genus of Blumea (inuleae) phylogenetic classification. Redai Nongye Kexue, 2011, 31, 81-86.
[35]
Chen, M. Studies on the active constituents of Blumea balsamifera. Master Degree Thesis., Shanghai Jiaotong University: Shanghai, China, 2009.
[36]
Pang, Y.; Wang, D.; Fan, Z.; Chen, X.; Yu, F.; Hu, X.; Wang, K.; Yuan, L. Blumea balsamifera-a phytochemical and pharmacological review. Molecules, 2014, 19(7), 9453-9477.
[http://dx.doi.org/10.3390/molecules19079453] [PMID: 24995927]
[37]
Koh, H.L.; Chua, T.K.; Tan, C.H. A guide to medicinal plants; World Scientific Publishing, 2009.
[http://dx.doi.org/10.1142/7113]
[38]
Jayalakshmi, S.; Patra, A.; Lal, V.K.; Ghosh, A.K. Pharmacognostical standardization of roots of Imperata cylindrica Linn (Poaceae). J. Pharmacol. Sci. Res., 2010, 2, 5.
[39]
Keshava, R.; Muniyappa, N.; Gope, R.; Ramaswamaiah, A.S. Anti-cancer effects of Imperata cylindrica leaf extract on human oral squamous carcinoma cell line scc-9 in vitro. Asian Pac. J. Cancer Prev., 2016, 17(4), 1891-1898.
[http://dx.doi.org/10.7314/APJCP.2016.17.4.1891] [PMID: 27221872]
[40]
Guruprasad, K.P.; Mascarenhas, R.; Gopinath, P.M.; Satyamoorthy, K. Studies on Brahma rasayana in male swiss albino mice: Chromosomal aberrations and sperm abnormalities. J. Ayurveda Integr. Med., 2010, 1(1), 40-44.
[http://dx.doi.org/10.4103/0975-9476.59826] [PMID: 21829300]
[41]
Parvathy, N.G.; Padma, R.; Renjith, V.; Rahate, K.P.; Saranya, T.S. Phytochemical screening and anthelmintic activity of methanolic extract of Imperata cylindrica. Int. J. Pharm. Pharm. Sci., 2012, 4, 232-234.
[42]
Kim, C.S.; Subedi, L.; Park, K.J.; Kim, S.Y.; Choi, S.U.; Kim, K.H.; Lee, K.R. Salicin derivatives from Salix glandulosa and their biological activities. Fitoterapia, 2015, 106, 147-152.
[http://dx.doi.org/10.1016/j.fitote.2015.08.013] [PMID: 26344424]
[43]
Matsunaga, K.; Shibuya, M.; Ohizumi, Y. Graminone B, a novel lignan with vasodilative activity from Imperata cylindrica. J. Nat. Prod., 1994, 57(12), 1734-1736.
[http://dx.doi.org/10.1021/np50114a020] [PMID: 7714541]
[44]
Mensah, MEE; Terlabi, EO; Komlaga, G Antiypertensive action of ethanolic extract of Imperata cylindrica leaves in animal models. J. Med. Plant Res., 2010, 1491.
[45]
Ruslin, R.; Asmawi, M.Z.; Rianse, U.; Sahidin, I.; Dhianawaty, D.; Soemardji, A.A.; Amalia, L. Anti-hypertensive activity of Alang – Alang (Imperata cylindrica (L.) Beauv. root methanolic extract on male Wistar rat. Inter. J. Res. Pharm. Sci., 2013, 4, 537-542.
[46]
Sulistyowati, E.; Hsu, J.H.; Cheng, Y.B.; Chang, F.R.; Chen, Y.F.; Yeh, J.L. Indonesian herbal medicine prevents hypertension-induced left ventricular hypertrophy by diminishing NADPH oxidase-dependent oxidative stress. Oncotarget, 2017, 8(49), 86784-86798.
[http://dx.doi.org/10.18632/oncotarget.21424] [PMID: 29156835]
[47]
Dey, A. Alstonia scholaris R.Br. (Apocynaceae): Phytochemistry and pharmacology: A concise review. J. Appl. Pharm. Sci., 2011, 1, 51-57.
[48]
Bello, I.; Asmawi, M.Z.; Nasiba, U.S.R.M.; Abubakar, K. Antihypertensive and vasorelaxant effect of Alstonia scholaris stem bark extracts and fractions. Int. J. Pharmacol., 2015, 11(4), 327-334. a
[http://dx.doi.org/10.3923/ijp.2015.327.334]
[49]
Bello, I.; Usman, N.S.; Mahmud, R.; Asmawi, M.Z. Mechanisms underlying the antihypertensive effect of Alstonia scholaris. J. Ethnopharmacol., 2015, 175, 422-431. b
[http://dx.doi.org/10.1016/j.jep.2015.09.031] [PMID: 26429073]
[50]
Ko, E.A.; Han, J.; Jung, I.D.; Park, W.S. Physiological roles of K+ channels in vascular smooth muscle cells. J. Smooth Muscle Res., 2008, 44(2), 65-81.
[http://dx.doi.org/10.1540/jsmr.44.65] [PMID: 18552454]
[51]
Waldron, G.J.; Cole, W.C. Activation of vascular smooth muscle K+ channels by endothelium-derived relaxing factors. Clin. Exp. Pharmacol. Physiol., 1999, 26(2), 180-184.
[http://dx.doi.org/10.1046/j.1440-1681.1999.03006.x] [PMID: 10065344]
[52]
Palanichamy, S.; Nagarajan, S. Analgesic activity of Cassia alata leaf extract and kaempferol 3-o-sophoroside. J. Ethnopharmacol., 1990, 29(1), 73-78.
[http://dx.doi.org/10.1016/0378-8741(90)90099-F] [PMID: 2345462]
[53]
Kazeem, M.I.; Azeez, G.A.; Ashafa, A.O.T. Effect of Senna alata (L) roxb (fabaceae) leaf extracts on alpha-amylase, alpha-glucosidase and postprandial hyperglycemia in rats. Trop. J. Pharm. Res., 2015, 14(10), 1843-1848.
[http://dx.doi.org/10.4314/tjpr.v14i10.15]
[54]
Reezal, I.; Somchif, M.N.; Abdul, R.M. In vitro antifungal properties of Cassia alata. Proceedings of the Regional Symposium on Environment and Natural Resources, 2002, pp. 656-649.
[55]
Sugumar, M.; Doss, D.V.A.; Maddisetty, P.N.P. Hepato-renal protective effects of hydroethanolic extract of Senna alata on enzymatic and nonenzymatic antioxidant systems in streptozotocin induced diabetic rats. Integr. Med. Res., 2016, 5(4), 276-283.
[http://dx.doi.org/10.1016/j.imr.2016.06.005] [PMID: 28462129]
[56]
Oladeji, OS; Adelowo, FE; Oluyori, AP; Bankole, DT Ethnobotanical description and biological activities of Senna alata. Evid. Compl. Alter. Med., 2020, 12, 2580259.
[57]
Gohil, K.J.; Patel, J.A.; Gajjar, A.K. Pharmacological review on Centella asiatica: A potential herbal cure-all. Indian J. Pharm. Sci., 2010, 72(5), 546-556.
[http://dx.doi.org/10.4103/0250-474X.78519] [PMID: 21694984]
[58]
Diwan, P.C.; Karwande, I.; Singh, A.K. Anti-anxiety profile of mandukparni Centella asiatica Linn in animals. Fitoterapia, 1991, 62, 255-257.
[59]
Jaganath, I.B.; Teik, N.L. Herbs, the green pharmacy of Malaysia; Vinpress: Kuala Lumpur, 2000.
[60]
Cesarone, M.R.; Laurora, G.; De Sanctis, M.T.; Incandela, L.; Grimaldi, R.; Marelli, C.; Belcaro, G. The microcirculatory activity of Centella asiatica in venous insufficiency. A double-blind study. Minerva Cardioangiol., 1994, 42(6), 299-304.
[PMID: 7936334]
[61]
Cesarone, M.R.; Incandela, L.; De Sanctis, M.T.; Belcaro, G.; Bavera, P.; Bucci, M.; Ippolito, E. Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella asiatica: a clinical prospective randomized trial with a microcirculatory model. Angiology, 2001, 52(Suppl. 2), S49-S54.
[http://dx.doi.org/10.1177/000331970105202S10] [PMID: 11666124]
[62]
Belcaro, G.V.; Grimaldi, R.; Guidi, G. Improvement of capillary permeability in patients with venous hypertension after treatment with TTFCA. Angiology, 1990, 41(7), 533-540.
[http://dx.doi.org/10.1177/000331979004100705] [PMID: 2389834]
[63]
De Sanctis, M.T.; Incandela, L.; Cesarone, M.R.; Grimaldi, R.; Belcaro, G.; Marelli, C. Acute effects of TTFCA on capillary filtration in severe venous hypertension. Panminerva Med., 1994, 36(2), 87-90.
[PMID: 7831065]
[64]
De Sanctis, M.T.; Belcaro, G.; Incandela, L.; Cesarone, M.R.; Griffin, M.; Ippolito, E.; Cacchio, M. Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebo-controlled, randomized, dose-ranging trial. Angiology, 2001, 52(Suppl. 2), S55-S59.
[http://dx.doi.org/10.1177/000331970105202S11] [PMID: 11666125]
[65]
Intharachatorn, T.; Srisawat, R. Antihypertensive effects of Centella asiatica extract. Int. Conf. Food Agri. Sci., 2013, pp. 122-126.
[66]
Hasimun, P.; Mulyani, Y.; Sulaeman, A.; Saraswati, D.A.E. Prevention of hypertension and arterial stiffness by combination of Centella asiatica and Curcuma longa in rats. Asian J. Biol. Sci., 2019, 12(2), 173-179.
[http://dx.doi.org/10.3923/ajbs.2019.173.179]
[67]
Sulistyowati, E.; Jan, R.L.; Liou, S.F.; Chen, Y.F.; Wu, B.N.; Hsu, J.H.; Yeh, J.L. Vasculoprotective effects of Centella asiatica, Justicia gendarussa and Imperata cylindrica decoction via the NOXs-ROS-NF-κB pathway in spontaneously hypertensive rats. J. Tradit. Complement. Med., 2019, 10(4), 378-388.
[http://dx.doi.org/10.1016/j.jtcme.2019.06.003] [PMID: 32695655]
[68]
Ahmad, W.; Jantan, I.; Bukhari, S.N.A. Tinospora crispa (L.) Hook. f. & Thomson: A review of its ethnobotanical, phytochemical, and pharmacological aspects. Front. Pharmacol., 2016, 7, 59.
[http://dx.doi.org/10.3389/fphar.2016.00059] [PMID: 27047378]
[69]
Kadir, F.A.; Othman, F.; Abdulla, M.A.; Hussan, F.; Hassandarvish, P. Effect of Tinospora crispa on thioacetamide-induced liver cirrhosis in rats. Indian J. Pharmacol., 2011, 43(1), 64-68.
[http://dx.doi.org/10.4103/0253-7613.75673] [PMID: 21455425]
[70]
Praman, S.; Mulvany, M.J.; Allenbach, Y.; Marston, A.; Hostettmann, K.; Sirirugsa, P.; Jansakul, C.; Allenbach, Y.; Marston, A.; Hostettmann, K.; Sirirugsa, P.; Jansakul, C. Effects of an n-butanol extract from the stem of Tinospora crispa on blood pressure and heart rate in anesthetized rats. J. Ethnopharmacol., 2011, 133(2), 675-686.
[http://dx.doi.org/10.1016/j.jep.2010.10.052] [PMID: 21040767]
[71]
Amom, Z.; Azman, K.F.; Ismail, N.A.; Shah, Z.M.; Arshad, M.S.M. An aqueous extract of Tinospora crispa possesses antioxidative properties and reduces atherosclerosis in hypercholesterolemic-induced rabbits. J. Food Biochem., 2011, 35(4), 1083-1098.
[http://dx.doi.org/10.1111/j.1745-4514.2010.00436.x]
[72]
Imphanban, K.; Kongkathip, N.; Dhumma-Upakorn, P.; Mesripong, R.; Kongkathip, B. Synthesis of N-formylnornuciferine with cardiotonic activity. Nat. Sci., 2009, 43, 738-744.
[73]
Praman, S.; Mulvany, M.J.; Williams, D.E.; Andersen, R.J.; Jansakul, C. Crude extract and purified components isolated from the stems of Tinospora crispa exhibit positive inotropic effects on the isolated left atrium of rats. J. Ethnopharmacol., 2013, 149(1), 123-132.
[http://dx.doi.org/10.1016/j.jep.2013.06.010] [PMID: 23778316]
[74]
El-Far, A.H.; Shaheen, H.M.; Alsenosy, A.W.; El-Sayed, Y.S.; Jaouni, S.K.; Mousa, S.A. Costus speciosus: Traditional uses, phytochemistry, and therapeutic potentials. Pharmacogn. Rev., 2018, 12(23), 120-127.
[http://dx.doi.org/10.4103/phrev.phrev_29_17]
[75]
El-Far, A.H.; El-Sayed, Y.S.; Shaheen, H.M. Back to the natural herbs. EC Pharmacol. Toxicol., 2016, 2, 273-276.
[76]
Emami, S.A.; Sahebkar, A.; Javadi, B. Sahebkar, A and Javadi, B. Paresthesia: A review of its definition, etiology and treatments in view of the traditional medicine. Curr. Pharm. Des., 2016, 22(3), 321-327.
[http://dx.doi.org/10.2174/1381612822666151112145348] [PMID: 26561077]
[77]
Saraf, A. Phytochemical and antimicrobial studies of medicinal plant Costus speciosus (Koen.). E-J. Chem., 2010, 7(s1), 405-413.
[http://dx.doi.org/10.1155/2010/605735]
[78]
Kavatagi, P.K.; Lakshman, H.C. Screening of potential Arbuscular mycorrhizal fungal isolates for Costus speciosus, a medicinal plant in unsterile soil. Nat. Environ. Poll. Technol., 2009, 8, 673-676.
[79]
Dubey, GP.; Agarawal, A.; Dubey, N.; Dubey, S.; Dubey, R.; Deborah, SM. A. novel herbal formulation advocated for the prevention and management of coronary heart disease. Patent no. WO2012020422A1, 2013.
[80]
Gauthaman, K.K.; Saleem, M.T.; Thanislas, P.T.; Prabhu, V.V.; Krishnamoorthy, K.K.; Devaraj, N.S.; Somasundaram, J.S. Cardioprotective effect of the Hibiscus rosa sinensis flowers in an oxidative stress model of myocardial ischemic reperfusion injury in rat. BMC Complement. Altern. Med., 2006, 6(1), 32-39.
[http://dx.doi.org/10.1186/1472-6882-6-32] [PMID: 16987414]
[81]
Rajenderan, M.T. Ethno medicinal uses and antimicrobial properties of Melastoma malabathricum. SEGi Review, 2010, 3, 34-44.
[82]
Zulaikah, M.; Nazlina, I.; Ahmad, I.B. Penindasan terpilih gen-gen Staphylococcus aureus rintang metisilin yang dirawat dengan ekstrak metanol Melastoma malabathricum. Sains Malays., 2008, 37, 107-113.
[83]
Lohézic-Le Dévéhat, F.; Bakhtiar, A.; Bézivin, C.; Amoros, M.; Boustie, J. Antiviral and cytotoxic activities of some Indonesian plants. Fitoterapia, 2002, 73(5), 400-405.
[http://dx.doi.org/10.1016/S0367-326X(02)00125-9] [PMID: 12165336]
[84]
Susanti, D.; Hasnah, M.S.; Farediah, A.; Rasadah, M.A.; Norio, A.; Mariko, K. Antioxidant and cytotoxic flavonoids from the flowers of Melastoma malabathricum. Food Chem., 2007, 103(3), 710-716.
[http://dx.doi.org/10.1016/j.foodchem.2006.09.011]
[85]
Mazura, M.P.; Susanti, D.; Rasadah, M.A. Anti-inflammatory action of components from Melastoma malabathricum. Pharm. Biol., 2007, 45(5), 372-375.
[http://dx.doi.org/10.1080/13880200701214797]
[86]
Koay, S.S. Establishment of cell suspension culture of Melastoma malabathricum L. for the production of anthocyanin., Doctoral Thesis: Universiti Sains Malaysia, 2008.
[87]
Wang, M.Y.; West, B.J.; Jensen, C.J.; Nowicki, D.; Su, C.; Palu, A.K.; Anderson, G. Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacol. Sin., 2002, 23(12), 1127-1141.
[PMID: 12466051]
[88]
Selvam, P.; Murugesh, N.; Witvrouw, M.; Keyaerts, E.; Neyts, J. Studies of antiviral activity and cytotoxicity of Wrightia tinctoria and Morinda citrifolia. Indian J. Pharm. Sci., 2009, 71(6), 670-672.
[http://dx.doi.org/10.4103/0250-474X.59550] [PMID: 20376221]
[89]
Palu, A.K.; Raevonne, A.S.; West, B.J.; Norman, K.; Jensen, J. The effects of Morinda citrifolia L. noni on high blood pressure: A mechanistic investigation and case study. ACS Symp. Ser., 2008, 993, 446-453.
[http://dx.doi.org/10.1021/bk-2008-0993.ch039]
[90]
Wigati, D.; Anwar, K.; Sudarsono, Nugroho, A.E.; Sudarsono and Nugroho, AE. Hypotensive activity of ethanolic extracts of Morinda citrifolia L. leaves and fruit in dexamethasone-induced hypertensive rat. J. Evid. Based Complementary Altern. Med., 2017, 22(1), 107-113.
[http://dx.doi.org/10.1177/2156587216653660] [PMID: 27313228]
[91]
Kumar, R.; Kumar, A.; Sharma, R.; Baruwa, A. Pharmacological review on natural ACE inhibitors. Pharm. Lett., 2010, 2, 273-293.
[92]
Nowak, D.; Gośliński, M.; Wesołowska, A.; Berenda, K.; Popławski, C Effects of acute consumption of noni and chokeberry juices vs. energy drinks on blood pressure, heart rate, and blood glucose in young adults. Evid. Compl. Alter. Med., 2019, 9, 6076751.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy